QuiVad
My list

Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on September 21, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 4.82% on March 10, 2025. The shaded band matches the twelve months of the first chart.

January 15, 2019 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
ActusRayPartners Limited0.90%+0.30 ptAugust 28, 2026
GSA Capital Partners LLP0.60%+0.06 ptSeptember 9, 2026
Worldquant LLC0.50%-0.08 ptSeptember 21, 2026

In the United States HNSBF (OTC): 62,228 shares sold short on August 31, 2026. FINRA names no fund.

On the other side: the funds that hold Hansa Biopharma AB Titelia

Follow by RSS

Get the moves on Hansa Biopharma AB by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

432 disclosures on record for this share.
DateFund% of capitalEnd of publication
September 21, 2026Worldquant LLC0.50%still open
September 9, 2026GSA Capital Partners LLP0.60%still open
August 28, 2026ActusRayPartners Limited0.90%still open
August 14, 2026GSA Capital Partners LLP0.59%
August 11, 2026Connor Clark & Lunn Investment Management Ltd.0.59%
August 7, 2026ActusRayPartners Limited0.89%
August 6, 2026GSA Capital Partners LLP0.60%
August 3, 2026Voleon Capital Management LP0.50%
July 17, 2026ActusRayPartners Limited0.90%
July 7, 2026GSA Capital Partners LLP0.59%
July 3, 2026Connor Clark & Lunn Investment Management Ltd.0.69%
June 24, 2026Connor Clark & Lunn Investment Management Ltd.0.79%
June 18, 2026Voleon Capital Management LP0.69%
June 18, 2026PDT Partners LLC0.59%
June 12, 2026Voleon Capital Management LP0.74%
June 10, 2026Voleon Capital Management LP0.97%
June 5, 2026Connor Clark & Lunn Investment Management Ltd.0.89%
June 2, 2026GSA Capital Partners LLP0.69%
May 28, 2026Voleon Capital Management LP1.11%
May 26, 2026Voleon Capital Management LP1.04%
May 20, 2026Voleon Capital Management LP0.90%
May 19, 2026Voleon Capital Management LP0.89%
May 15, 2026Voleon Capital Management LP1.07%
May 12, 2026ActusRayPartners Limited0.80%
May 6, 2026Connor Clark & Lunn Investment Management Ltd.0.90%
April 29, 2026GSA Capital Partners LLP0.70%
April 27, 2026Voleon Capital Management LP1.10%
April 23, 2026Voleon Capital Management LP1.01%
April 22, 2026Voleon Capital Management LP0.91%
April 7, 2026Voleon Capital Management LP0.87%
April 2, 2026Connor Clark & Lunn Investment Management Ltd.0.88%
March 25, 2026ActusRayPartners Limited0.71%
March 24, 2026Voleon Capital Management LP0.99%
March 20, 2026Voleon Capital Management LP1.08%
March 18, 2026GSA Capital Partners LLP0.60%
March 16, 2026ActusRayPartners Limited0.62%
March 11, 2026Voleon Capital Management LP1.10%
March 9, 2026ActusRayPartners Limited0.52%
February 27, 2026Voleon Capital Management LP1.00%
February 25, 2026GSA Capital Partners LLP0.50%
February 18, 2026Voleon Capital Management LP0.90%
February 16, 2026Voleon Capital Management LP0.84%
February 12, 2026Voleon Capital Management LP0.77%
February 11, 2026GSA Capital Partners LLP0.50%
February 9, 2026Voleon Capital Management LP0.89%
January 28, 2026Connor Clark & Lunn Investment Management Ltd.0.99%
January 22, 2026Voleon Capital Management LP0.97%
January 14, 2026Voleon Capital Management LP1.07%
January 13, 2026Connor Clark & Lunn Investment Management Ltd.0.99%
January 7, 2026Voleon Capital Management LP1.15%

Download 432 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Hansa Biopharma AB, source Finansinspektionen, data as at September 21, 2026, https://www.quivad.com/action/hansa-biopharma-ab